drug price
-
News
Is evidence-based medicine an illusion? The threat is that Big Pharma's financial interests trump the common good.
Evidence-based medicine has been corrupted by corporate interests, failed regulation and the commercialization of academia, argue Jon Jureidini…
Leggi » -
News
Antitrust. Fine of around 3.5 million euros to the Leadiant group (formerly Sigma-Tau Pharmaceuticals) for abuse of dominant position
According to the Authority, since June 2017 it has imposed unjustifiably heavy prices on the NHS for the sale of a life-saving drug. Analogs…
Leggi » -
News
Lucia Aleotti (Menarini): if the price of drugs drops, the pharmaceutical sector risks default
Pharmaceutical industry, Aleotti denounces the risk of default on money – 18 May 2022 “We are losing competitiveness by leaps and bounds. We…
Leggi » -
News
Seminar Dr. Magrini – AIFA: Access to the drug market
A seminar was held on Wednesday 11 May at the Department of Pharmacy and Biotechnology of the University of Bologna, the speaker…
Leggi » -
News
AIFA: report on timing. An average of 429 days pass from the approval of a drug by the EMA to its marketing in Italy
Report on the timing of drug pricing and reimbursement procedures in the four-year period 2018-2021 AIFA - 13 April 2022 The Agency…
Leggi » -
News
“Horizon Scanning: scenario of incoming medicines”. AIFA publishes the 2022 Report
In Europe, during 2021, 79 new medicines were authorized, of which 61 contain new active substances (25…
Leggi » -
News
If it expires, don't throw it away. App to donate medicines
Every year in Italy alone, about eight billion tablets are thrown away in the trash, almost 30% of the 24 billion…
Leggi » -
News
Cry of alarm from drug wholesalers: unsustainable costs. Scaccabarozzi: risk of drug shortage
Wholesalers, alarm on the economic sustainability of pharmaceutical distribution Skyrocketing energy costs, fuel price increases and NHS remuneration at…
Leggi » -
News
AIFA-led European plan against drug shortages
A three-year plan to coordinate and harmonize existing national medicines shortage systems. It is the project of…
Leggi » -
News
Parliament approved the law on rare diseases and orphan drugs. However, Aifa suspends access to the Fund for the reimbursement of orphan drugs
The Parliament has just unanimously approved the law on rare diseases with a strong reference to orphan drugs, both for…
Leggi »